Table 1.
Relation between intratumoral miR-34a expression and clinical characteristics in patients with gastric cancer (n=76)
| Items | Patients, n (%) | miR-34a expression | P | |
|---|---|---|---|---|
| Low | High | |||
| All patients | 76 (100) | 36 | 40 | |
| Age* | 0.646 | |||
| ≤65 years | 38 (50.0) | 19 | 19 | |
| >65 years | 38 (50.0) | 17 | 21 | |
| Gender | 0.580 | |||
| Female | 53 (69.7) | 24 | 29 | |
| Male | 23 (30.3) | 12 | 11 | |
| Localization | 0.506 | |||
| Proximal | 17 (22.4) | 8 | 9 | |
| Middle | 30 (39.5) | 12 | 18 | |
| Distal | 29 (38.2) | 16 | 13 | |
| Differentiation | 0.276 | |||
| Well | 12 (15.8) | 6 | 6 | |
| Moderately | 19 (25.0) | 6 | 13 | |
| Poorly | 45 (59.2) | 24 | 21 | |
| Lauren classification | 0.034 | |||
| Intestinal type | 57 (75.0) | 23 | 34 | |
| Diffusetype | 19 (25.0) | 13 | 6 | |
| T stage | 0.146 | |||
| T1 | 7 (9.2) | 2 | 5 | |
| T2 | 6 (7.9) | 1 | 5 | |
| T3 | 10 (13.2) | 7 | 3 | |
| T4 | 53 (69.7) | 26 | 27 | |
| N stage | 0.254 | |||
| N0 | 25 (32.9) | 11 | 14 | |
| N1 | 8 (10.5) | 2 | 6 | |
| N2 | 17 (22.4) | 7 | 10 | |
| N3 | 26 (34.2) | 16 | 10 | |
| TNM stage | 0.357 | |||
| I | 10 (13.2) | 3 | 7 | |
| II | 19 (25.0) | 8 | 11 | |
| III | 47 (61.8) | 25 | 22 | |
| Tumor size* | 0.981 | |||
| <3.5 cm | 40 (52.6) | 19 | 21 | |
| ≥3.5 cm | 36 (47.4) | 17 | 19 | |
TNM: Tumor node metastasis. *Split at median.